Delivery Order SPE2DH25D0001-SPE2D425F541B

Abbott Laboratories Inc., through its Abbott Point of Care division, has been awarded a delivery order valued at $1,938.56 by the Medical Supply Chain (Defense) federal agency. This fixed-price delivery order with economic price adjustment authority was issued on August 14, 2025, with an ultimate completion date of August 18, 2025, and will be performed in North Chicago, Illinois. The contract was awarded through full and open competition with no set-aside designation, reflecting the competitive nature of the procurement. As a child contract, this delivery order likely derives from a larger Blanket Purchase Agreement or Indefinite Delivery Vehicle under which Abbott maintains established pricing and terms for medical diagnostic products and point-of-care testing supplies.

Abbott Laboratories Inc. is a global healthcare company specializing in medical devices, diagnostics, and pharmaceuticals, with extensive federal contracting experience predominantly serving the Department of Veterans Affairs. The company's federal portfolio includes supply of critical diagnostic equipment such as immunoassay analyzers, glucometers, chemistry analyzers, and point-of-care testing devices, as well as specialized cardiovascular technologies. This delivery order aligns with Abbott's established federal contract mechanisms, including multiple Blanket Purchase Agreements under General Services Administration Schedule contracts such as the Critical Analyzers, Laboratory (FSS-66-III) Schedule and the In-Vitro Diagnostics, Reagents, Test (FSS-65-VII) Schedule, enabling efficient procurement of essential medical diagnostic products and testing supplies for federal healthcare operations.